After finishing at $8.99 in the prior trading day, Braskem S.A. ADR (NYSE: BAK) closed at $10.56, up 17.46%. In other words, the price has increased by $+1.57 from its previous closing price. On the day, 3960282 shares were traded.
Ratios:
Our goal is to gain a better understanding of BAK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 15.01 whereas as Long-Term Debt/Eq ratio is at 14.07.
On July 05, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $11.50 to $11.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 4.14B and an Enterprise Value of 12.35B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.13 while its Price-to-Book (P/B) ratio in mrq is 5.12. Its current Enterprise Value per Revenue stands at 0.17 whereas that against EBITDA is 3.76.
Stock Price History:
The Beta on a monthly basis for BAK is 1.92, which has changed by 67.89% over the last 52 weeks, in comparison to a change of 32.31% over the same period for the S&P500. Over the past 52 weeks, BAK has reached a high of $12.67, while it has fallen to a 52-week low of $6.26. The 50-Day Moving Average of the stock is 7.84, while the 200-Day Moving Average is calculated to be 8.71.
Shares Statistics:
The stock has traded on average 1.02M shares per day over the past 3-months and 1.28M shares per day over the last 10 days, according to various share statistics. A total of 172.53M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of Feb 29, 2024 were 2.55M with a Short Ratio of 2.24, compared to 2.36M on Jan 31, 2024.
Earnings Estimates
Its stock is currently analyzed by 0 different market analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0.21. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.98 and -$0.98 for the fiscal current year, implying an average EPS of -$0.98. EPS for the following year is -$0.04, with 1 analysts recommending between -$0.04 and -$0.04.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $14.39B, while the lowest revenue estimate was $14.39B, resulting in an average revenue estimate of $14.39B. In the same quarter a year ago, actual revenue was $14.13B, up 1.90% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $15.16B in the next fiscal year. The high estimate is $15.16B and the low estimate is $15.16B. The average revenue growth estimate for next year is up 5.40% from the average revenue estimate for this year.
